Lv3
360 积分 2025-11-26 加入
InhibitWin duo: Rational design and structural insights into dual PARP/HDAC inhibitors for synergistic DNA repair disruption and epigenetic modulation
8天前
已完结
EDG-7500, A First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, And Pharmacokinetics In Healthy Adults
16天前
已完结
Progress in Targeting the Untouchables: Emerging Approaches for Hard-to-Drug Cancer Targets
1个月前
已关闭
Current advances and development strategies of orally bioavailable PROTACs
2个月前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
2个月前
已完结
RAS mutation–specific responses to paralog- and state-selective RAS inhibitors
2个月前
已完结
Menin inhibitors for adult acute myeloid leukemia: 2025 update
2个月前
已完结
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
2个月前
已完结
A molecular glue halts RAS–MAPK signaling
2个月前
已完结
Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
3个月前
已完结
皖公网安备34019202002308
